Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-018223

Director sold 40,000 shares at an average $97.60 ($3,903,914)

  • Director acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KUEBLER CHRISTOPHER A Director 2018-03-06 Option exercise +2,600 $5.14 $13,364 43,100 D
KUEBLER CHRISTOPHER A Director 2018-03-06 Sale −2,600 $100.30 $260,780 40,500 D
KUEBLER CHRISTOPHER A Director 2018-03-07 Option exercise +27,400 $5.14 $140,836 67,900 D
KUEBLER CHRISTOPHER A Director 2018-03-07 Option exercise +10,000 $9.24 $92,400 77,900 D
KUEBLER CHRISTOPHER A Director 2018-03-07 Sale −37,400 $97.41 $3,643,134 40,500 D
Derivatives
KUEBLER CHRISTOPHER A Director 2018-03-06 Option exercise · Stock Option −2,600 27,400 D
KUEBLER CHRISTOPHER A Director 2018-03-07 Option exercise · Stock Option −27,400 0 D
KUEBLER CHRISTOPHER A Director 2018-03-07 Option exercise · Stock Option −10,000 30,000 D
Open-market sales · 40,000 sh · avg $97.60 · $3,903,914
Loading xslF345X03/doc4.xml…